Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketamine added to bupivacaine for postoperative pain after lumbar fusion surgery
IRCT20160307026950N63Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Bupivacaine + ketamine with Bupivacaine + dexmedetomidine (2 arms). Primary endpoints: Pain intensity at 2 hours after lumbar fusion surgery, Pain intensity at 6 hours after lumbar fusion surgery and 2 more. Started Aug 2024; status: completed.
02
Drugs
bupivacaineketaminedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20160307026950N63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N63.